97 related articles for article (PubMed ID: 23856938)
1. Expression of membrane drug efflux transporters in the sigmoid colon of HIV-infected and uninfected men.
De Rosa MF; Robillard KR; Kim CJ; Hoque MT; Kandel G; Kovacs C; Kaul R; Bendayan R
J Clin Pharmacol; 2013 Sep; 53(9):934-45. PubMed ID: 23856938
[TBL] [Abstract][Full Text] [Related]
2. Impact of drug transporters on cellular resistance towards saquinavir and darunavir.
König SK; Herzog M; Theile D; Zembruski N; Haefeli WE; Weiss J
J Antimicrob Chemother; 2010 Nov; 65(11):2319-28. PubMed ID: 20817741
[TBL] [Abstract][Full Text] [Related]
3. Depletion of natural killer cells in the colonic lamina propria of viraemic HIV-1-infected individuals.
Mela CM; Steel A; Lindsay J; Gazzard BG; Gotch FM; Goodier MR
AIDS; 2007 Oct; 21(16):2177-82. PubMed ID: 18090044
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Alters Intestinal Expression of Drug Transporters and Metabolic Enzymes: Implications for Antiretroviral Drug Disposition.
Kis O; Sankaran-Walters S; Hoque MT; Walmsley SL; Dandekar S; Bendayan R
Antimicrob Agents Chemother; 2016 May; 60(5):2771-81. PubMed ID: 26902756
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
[TBL] [Abstract][Full Text] [Related]
6. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
[TBL] [Abstract][Full Text] [Related]
7. Transporters for Antiretroviral Drugs in Colorectal CD4+ T Cells and Circulating α4β7 Integrin CD4+ T Cells: Implications for HIV Microbicides.
Mukhopadhya I; Murray GI; Duncan L; Yuecel R; Shattock R; Kelly C; Iannelli F; Pozzi G; El-Omar EM; Hold GL; Hijazi K
Mol Pharm; 2016 Sep; 13(9):3334-40. PubMed ID: 27467446
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 is rarely detected in blood and colon myeloid cells during viral-suppressive antiretroviral therapy.
Cattin A; Wiche Salinas TR; Gosselin A; Planas D; Shacklett B; Cohen EA; Ghali MP; Routy JP; Ancuta P
AIDS; 2019 Jul; 33(8):1293-1306. PubMed ID: 30870200
[TBL] [Abstract][Full Text] [Related]
9. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
[TBL] [Abstract][Full Text] [Related]
10. The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells.
Sternfeld T; Schmid M; Tischleder A; Mudra S; Schlamp A; Kost BP; Gruber R; Youle M; Bogner JR; Goebel FD
Antivir Ther; 2007; 12(5):769-78. PubMed ID: 17713160
[TBL] [Abstract][Full Text] [Related]
11. Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trial.
Chege D; Kovacs C; la Porte C; Ostrowski M; Raboud J; Su D; Kandel G; Brunetta J; Kim CJ; Sheth PM; Kaul R; Loutfy MR
AIDS; 2012 Jan; 26(2):167-74. PubMed ID: 22089379
[TBL] [Abstract][Full Text] [Related]
12. Intracellular and plasma pharmacokinetics of nelfinavir and M8 in HIV-infected patients: relationship with P-glycoprotein expression.
Ford J; Cornforth D; Hoggard PG; Cuthbertson Z; Meaden ER; Williams I; Johnson M; Daniels E; Hsyu P; Back DJ; Khoo SH
Antivir Ther; 2004 Feb; 9(1):77-84. PubMed ID: 15040539
[TBL] [Abstract][Full Text] [Related]
13. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
14. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients.
Latronico T; Liuzzi GM; Riccio P; Lichtner M; Mengoni F; D'Agostino C; Vullo V; Mastroianni CM
AIDS; 2007 Mar; 21(6):677-84. PubMed ID: 17413688
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir.
Janneh O; Anwar T; Jungbauer C; Kopp S; Khoo SH; Back DJ; Chiba P
Antivir Ther; 2009; 14(7):965-74. PubMed ID: 19918100
[TBL] [Abstract][Full Text] [Related]
17. Comparison of time to undetectable HIV viral load in the first 16 weeks after the start of three and four antiretroviral regimens.
Manavi K; Scott G
Int J STD AIDS; 2006 Aug; 17(8):522-4. PubMed ID: 16925897
[TBL] [Abstract][Full Text] [Related]
18. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
[TBL] [Abstract][Full Text] [Related]
19. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
[TBL] [Abstract][Full Text] [Related]
20. Virological characterization of an infection with a dual-tropic, multidrug-resistant HIV-1 and further evolution on antiretroviral therapy.
Masquelier B; Capdepont S; Neau D; Peuchant O; Taupin JL; Coakley E; Lie Y; Carpentier W; Dabis F; Fleury HJ;
AIDS; 2007 Jan; 21(1):103-6. PubMed ID: 17148975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
